ALS: A disorder with a devastating physical and psychological impact
The impact of Amyotrophic Lateral Sclerosis (ALS) is felt around the world by people living with the disorder and their loved ones.
Many people diagnosed with ALS in Europe have had a long and difficult road to diagnosis:
the majority spend approximately one-third of their disease course searching for a diagnosis.
Sadly, the average life expectancy from symptom onset is two to five years.
Each year, a similar number of people die from ALS as are newly diagnosed.
There is only one approved therapy for the treatment of ALS
without a specific genetic marker in the European Union.
People living with ALS face rapid and relentless loss of physical functions, including deteriorating muscle function, loss of ability to move, speak and breathe unaided and eventually, death.
This loss of independence has a devastating emotional impact, not only on those living with the disorder but also their loved ones. In surveys conducted in four European countries, around a third of people living with ALS reported that they experience moderate or severe depression, while nearly half of caregivers showed signs of probable psychological distress.
Together for ALS began as a way to share the experiences of people living with ALS and their loved ones. Supported by patient advocacy groups across Europe, including Stichting ALS in The Netherlands, ARSLA in France, Fundación Luzón in Spain and EUpALS (European Organization for Professionals and Patients with ALS), partnered with Amylyx.
Together for ALS is continuing to collect stories to raise awareness, share the devastating consequences that people living with ALS and their loved ones face, and inspire others to feel empowered to share their stories as well.
How could you participate in the campaign?
#1
If you or someone you know is living with ALS and you would like to share your story, contact your local patient advocacy group or EUpALS
#2
If you are a patient advocacy group and would like to get involved, contact us via email using info@amylyx.com
Amylyx’s commitment
Amylyx is committed to supporting and creating more moments for the neurodegenerative community through the discovery and development of innovative new treatments.
It is our mission to end the suffering caused by neurodegenerative diseases. Every day we strive for better therapies. We question the unquestioned, always in search of new solutions.
Our science is our humanity. From the individual neuron to the entire neurodegenerative disease community, we strive to enhance our knowledge, identify research opportunities, and grow our relationships to improve the lives of people with neurodegenerative diseases and of their families.
Founded in the U.S. nearly 10 years ago, we now have a presence in ten countries including the U.S., Canada and across Europe.